BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioNJ - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioNJ
X-ORIGINAL-URL:https://bionj.org
X-WR-CALDESC:Events for BioNJ
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240306T120000
DTEND;TZID=America/New_York:20240306T130000
DTSTAMP:20260504T133749
CREATED:20240130T152008Z
LAST-MODIFIED:20240130T152134Z
UID:10742-1709726400-1709730000@bionj.org
SUMMARY:Integrating AI and Robotics to Discover New Drugs Faster
DESCRIPTION:FREE Webinar: Integrating AI and Robotics to Discover New Drugs Faster \n\n\n\nWednesday\, March 6\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this one-hour webinar where experts will use Iktos’ AI-driven platform to explore the synergy between artificial intelligence and robotics in the design and synthesis of novel molecules for drug discovery and optimization.  \n\n\n\nFrom handling diverse molecules\, reactions and exit vectors to optimizing reactants\, procedures and the number of steps\, this groundbreaking approach is poised to reshape the future of drug discovery.  \n\n\n\nBy streamlining research processes and addressing current weaknesses related to sub-optimal workflows and time-consuming manual tasks\, AI solutions have the potential to deliver a drug candidate within 24 months with just two chemists and one robot\, a significant reduction compared to the conventional requirement of 10 people and 30 months. \n\n\n\nInvite your entire Team to attend this FREE webinar\, including your scientists\, researchers\, R&D leads and business development professionals! \n\n\n\nSpeakers: \n\n\n\n\n\n\n\n\nQuentin Perron\, Ph.D.Co-Founder & Chief Scientific Officer\, Iktos \n\n\n\nAfter completing his post-doc fellowship at UCLA where Dr. Perron worked on the total synthesis of Brasillicardin A\, a complex natural molecule known for having a potent immunosuppressive activity\, he was a medicinal chemist in CNS indications at Laboratoires Servier. He later switched to data science and chemoinformatics at Quinten\, a company specialized in data science services. In 2016\, with his business partners Yann Gaston-Mathé and Nicolas Do Huu\, Dr. Perron co-founded Iktos\, a start-up company developing AI technologies for new drug design. \n\n\n\n\n\n\n\n\n\nFranck Le Vaillant\, Ph.D.\, MBASenior Scientist & Deputy Lab Head\, Iktos \n\n\n\nUpon completion of his Ph.D.\, Dr. Le Vaillant became a SNF-postdoctoral fellow to the Max-Planck-Institute für Kohlenforschung in Mülheim an der Ruhr where he developed Ni-catalyzed C-O bond formations using nitrous oxide. He later started the Labcom HitCat\, a joint lab between the company Seqens and the group of Prof. Géraldine Masson (CNRS). Dr. Le Vaillant joined Iktos in July 2022\, where he works on the installation\, development and utilization of the Iktos Robotics Platform for Drug Discovery. \n\n\n\n\n\n\n\n\nWe hope to see you on March 6\, 2024 for this FREE educational webinar.
URL:https://bionj.org/event/integrating-ai-and-robotics-to-discover-new-drugs-faster/
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
END:VCALENDAR